Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

Richard Nixon; Gorana Capkun-Niggli; Niklas Bergvall; Sofia Dias

doi:10.1185/03007995.2014.971359

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

Richard Nixon, Gorana Capkun-Niggli, Niklas Bergvall, Sofia Dias

Research output: Contribution to journal › Article (Academic Journal) › peer-review

2 Citations (Scopus)

Original language	English
Article number	971359
Pages (from-to)	51-52
Number of pages	2
Journal	Current Medical Research and Opinion
Volume	31
Issue number	1
DOIs	https://doi.org/10.1185/03007995.2014.971359
Publication status	Published - 1 Jan 2015

Access to Document

10.1185/03007995.2014.971359

Handle.net

Persistent link

Cite this

Nixon, R., Capkun-Niggli, G., Bergvall, N., & Dias, S. (2015). Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27. Current Medical Research and Opinion, 31(1), 51-52. [971359]. https://doi.org/10.1185/03007995.2014.971359

Nixon, Richard ; Capkun-Niggli, Gorana ; Bergvall, Niklas et al. / Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27. In: Current Medical Research and Opinion. 2015 ; Vol. 31, No. 1. pp. 51-52.

@article{90fdd6cf485540c798740eb2915f8034,

title = "Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27",

author = "Richard Nixon and Gorana Capkun-Niggli and Niklas Bergvall and Sofia Dias",

year = "2015",

month = jan,

day = "1",

doi = "10.1185/03007995.2014.971359",

language = "English",

volume = "31",

pages = "51--52",

journal = "Current Medical Research and Opinion",

issn = "0300-7995",

publisher = "Informa Healthcare",

number = "1",

}

Nixon, R, Capkun-Niggli, G, Bergvall, N & Dias, S 2015, 'Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27', Current Medical Research and Opinion, vol. 31, no. 1, 971359, pp. 51-52. https://doi.org/10.1185/03007995.2014.971359

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27. / Nixon, Richard; Capkun-Niggli, Gorana; Bergvall, Niklas et al.

In: Current Medical Research and Opinion, Vol. 31, No. 1, 971359, 01.01.2015, p. 51-52.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

AU - Nixon, Richard

AU - Capkun-Niggli, Gorana

AU - Bergvall, Niklas

AU - Dias, Sofia

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84918783004&partnerID=8YFLogxK

U2 - 10.1185/03007995.2014.971359

DO - 10.1185/03007995.2014.971359

M3 - Article (Academic Journal)

C2 - 25265130

AN - SCOPUS:84918783004

VL - 31

SP - 51

EP - 52

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 1

M1 - 971359

ER -

Nixon R, Capkun-Niggli G, Bergvall N, Dias S. Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27. Current Medical Research and Opinion. 2015 Jan 1;31(1):51-52. 971359. doi: 10.1185/03007995.2014.971359

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

Access to Document

Handle.net

Other files and links

NIRG: Bayesian evidence synthesis of multiple outcomes

Cite this

Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: A systematic review and mixed treatment comparison. Curr Med Res Opin 2014;30:613-27

Access to Document

Handle.net

Other files and links

Projects

NIRG: Bayesian evidence synthesis of multiple outcomes

Cite this